Adagio Medical (ADGM) Fundamental Analysis: Revenue, Earnings & Valuation

0.63 / 10

Underperform

Fundamental health is poor, scoring 0.6/10. Profit‑MV and Asset‑MV are modest positives, while cash metrics and ROE are deeply negative, leading to an Underperform rating.

Analysis Checks(3/10)

ROA (%)

Value-54.45

Score0/3

Weight19.68%

1M Return-6.12%

Annualized return on equity (%)

Value-312.23

Score0/3

Weight18.80%

1M Return-5.73%

Profit-MV

Value0.41

Score2/3

Weight-17.99%

1M Return3.26%

Cash-UP

Value-0.01

Score2/3

Weight16.40%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-72.60

Score0/3

Weight19.68%

1M Return-6.12%

ROE (diluted) (%)

Value-38.92

Score0/3

Weight19.75%

1M Return-5.82%

Asset-MV

Value-0.48

Score2/3

Weight-19.22%

1M Return3.42%

ROE (%)

Value-234.17

Score0/3

Weight18.80%

1M Return-5.73%

Cash-MV

Value-0.09

Score1/3

Weight14.14%

1M Return-3.56%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight9.95%

1M Return-2.37%

Is ADGM undervalued or overvalued?

ADGM scores 0.63/10 on fundamentals and holds a Premium valuation at present. Backed by its -234.17% ROE, -57771.53% net margin, -0.34 P/E ratio, -20.34 P/B ratio, and 55.34% earnings growth, these metrics solidify its Underperform investment rating.